by SOTO USA | Mar 10, 2016 | January, 2004
Vitreshchak TV, Poleshchuk VV, Piradov MA Biomed Khim 2004 Jan-Feb;50(1):92-9 Institute of Neurology, Russian Academy of Medical Sciences, Volokolamskoe Shosse 80, 125367 Moscow, Russia. Content of neurotransmitter amino acids before and after treatment with...
by SOTO USA | Mar 10, 2016 | October, 2003
Xue, Y The Journal of Chinese Medicine 2003 Oct ; 73 ABSTRACT: This article discusses the aetiology and pathology of Parkinson’s disease, its pattern identification according to Chinese medicine, and its treatment by body acupuncture, scalp acupuncture, pricking to...
by SOTO USA | Mar 10, 2016 | October, 2003
Montgomery AJ, McTavish SF, Cowen PJ, Grasby PM Am J Psychiatry 2003 Oct;160(10):1887-9 Imperial College, School of Medicine, University Department of Psychiatry, Warneford Hospital, Oxford, UK. OBJECTIVE: Extracellular dopamine concentrations were estimated through...
by SOTO USA | Mar 10, 2016 | October, 2003
Shults CW Curr Med Chem 2003 Oct;10(19):1917-21 Department of Neurosciences, University of California, San Diego, LaJolla, CA 92093-0662, USA Coenzyme Q(10) (ubiquinone), which serves as the electron acceptor for complexes I and II of the mitochondrial electron...
by SOTO USA | Mar 10, 2016 | April, 2003
Panikar, D.; Kishore, A Neurology India 2003 Apr ; 51(2): 167-75 ABSTRACT: Dopaminerigic replacement therapy with levodopa/carbidopais still the cornerstone for the treatment of Parkinson’s disease (PD). However, the medical management of PD is complicated by the...
by SOTO USA | Mar 10, 2016 | January, 2003
Beal, M.F.; Shults, C.W. Biofactors 2003 18(1-4): 153-61 ABSTRACT: There is increasing interest in the potential usefulness of coenzyme Q10 (CoQ10) to treat both mitochondrial disorders as well as neuro degenerative diseases such as Parkinson’s Disease (PD),...
by SOTO USA | Mar 10, 2016 | January, 2003
Sudha, K.; Rao, A.V.; Rao, S.; Rao, A. Neurology India 2003 Jan; 51(1): 60-2 ABSTRACT: Erythrocyte lipid peroxidation, oxidative hemolysis, erythrocyte antioxidant enzymes, viz. superoxide dismutase, glutathione reductase, glutathione peroxidase, catalase and plasma...
by SOTO USA | Mar 10, 2016 | December, 2002
Thompson, M.; Thompson, L. Journal of Neurotherapy 2002 Win; 6/4: 51-70 ABSTRACT: Background: This paper presents a theoretical framework for using a combination of EEG biofeedback plus regular biofeedback with clients who have movement disorders. Method: A case...
by SOTO USA | Mar 10, 2016 | October, 2002
Miyai, I.; Fujimoto, Y.; Yamamoto, H.; Ueda, Y.; Saito, T.; Nozaki, S.; Kang, J. Archives of Physical Medicine and Rehabilitation 2002 Oct ; 83(10): 1370-3 ABSTRACT: OBJECTIVE: To investigate whether body weight-supported treadmill training (BWSTT) is of long-term...
by SOTO USA | Mar 10, 2016 | October, 2002
Kaur D, Andersen JK Aging Cell 2002 Oct;1(1):17-21 Buck Institute for Age Research, 8001 Redwood Blvd, Novato, CA 94945, USA. Levels of iron are increased in the brains of Parkinson’s disease (PD) patients compared to age-matched controls. This has been postulated...
by SOTO USA | Mar 10, 2016 | September, 2002
Duval, C.; Lafontaine, D.; Hebert, J.; Leroux, A.; Panisset, M.; Boucher, J.P. Journal of Manipulative and Physiological Therapeutics 2002 Sep; 25(7): 455-64 ABSTRACT: OBJECTIVE: To quantify changes of evoked stretch responses(ESR) in the most rigid arm of patients...
by SOTO USA | Mar 10, 2016 | August, 2002
Rivera-Martinez S, Wells M, Capobianco J Journal of the American Osteopathic Association Aug 2002;102(8):417-422. While providing osteopathic manipulative treatment to patients with Parkinson’s disease at the clinic of the New York College of Osteopathic...
by SOTO USA | Mar 10, 2016 | July, 2002
Hernandez-Reif, M.; Field, T.; Largie, S.; Cullen, C.; Beutler, J.; Sanders, C.; Weiner, W.; Rodriguez-Bateman, D.; Zelaya, L.; Schanber, S.;Kuhn,C. Parkinson’s disease symptoms are differentially affected by massage therapy vs. progressive muscle relaxation: a pilot...
by SOTO USA | Mar 10, 2016 | March, 2002
Thompson, M.; Thompson, L.; Journal of Neurotherapy 2002 Spr; 6/1: 100-102 ABSTRACT: This paper presents a theoretical framework for using a combination of neurofeedback and biofeedback with clients who have dystonia (or a combination of dystonia and Parkinson’s...
by SOTO USA | Mar 10, 2016 | March, 2002
Flanagan M Dynamic Chiropractic 2002 Mar; 20(7) In the first part of this series, we discussed the role of the craniosacral primary respiratory rhythm in cranial hydrodynamics. In the second article, we discussed the role of the accessory drainage system (vertebral...
